Condition
Cortisol Excess
Total Trials
6
Recruiting
3
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting3
Completed1
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07296484Phase 2Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT05307328Phase 2Completed
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
NCT05315388Not ApplicableActive Not RecruitingPrimary
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
NCT06443268Recruiting
Cerebrovascular Disease: Quality of Life (CODE: QoL)
NCT06324084Recruiting
PATHophysiology of OSteoporosis: Role of Hidden Cortisol Excess and Its Predictors in Bone Fragility
NCT05762549Unknown
Prevalence of Hidden Hypercortisolism in Osteoporosis
Showing all 6 trials